Nonalcoholic fatty liver disease is a major global health concern with increasing prevalence,
associated with obesity and metabolic syndrome. Recently, quantitative ultrasound-based …

Non-alcoholic fatty liver disease is a condition that is characterized by the presence of> 5%
fat in the liver and affects more than one billion people worldwide. If adequate and early …

Background & Aims Liver biopsy analysis is the standard method used to diagnose
nonalcoholic fatty liver disease (NAFLD). Advanced magnetic resonance imaging is a …

Hepatic steatosis is a frequently encountered imaging finding that may indicate chronic liver
disease, the most common of which is non-alcoholic fatty liver disease. Non-alcoholic fatty …

In the world, nonalcoholic fatty liver disease (NAFLD) accounts for majority of diffuse hepatic
diseases. Notably, substantial liver fat accumulation can trigger and accelerate hepatic …

Hepatic steatosis, the accumulation of lipids within hepatocytes, is a common condition. The
prevalence of its most frequent manifestation, nonalcoholic fatty liver disease (NAFLD), has …

Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in the United
States. While the American Association for the Study of Liver Diseases guidelines define …

Hepatic steatosis is the most prevalent liver disorder in the developed world. It is closely
associated with features of metabolic syndrome, especially insulin resistance and obesity …

Hepatic steatosis as the most prevalent liver disorder can either be related to alcoholic liver
disease (ALD) or non-alcoholic fatty liver disease (NAFLD). In both conditions, hepatocytes …

Nonalcoholic fatty liver disease, characterized by excessive accumulation of fat in the liver,
is the most common chronic liver disease worldwide. The current standard for the detection …